NYSE:LLY

Eli Lilly Stock News

Healthcare > Drug Manufacturers - General

Buy LLY

*Your capital is at risk

$1,185.71

-6.23 (-0.523%)

At Close: Aug 07, 2026

Eli Lilly gets FDA complete response letter for skin treatment after inspection of third-party facility

06:59am, Monday, 02'nd Oct 2023

Eli Lilly & Co. said Monday the U.S. Food and Drug Administration has issued a complete response letter for its lebrikizumab, a treatment for moderate-to-severe atopic dermatitis, after an inspection

U.S. FDA declines to approve Eli Lilly's skin disease drug

06:54am, Monday, 02'nd Oct 2023

The U.S. Food and Drug Administration has declined to approve Eli Lilly's drug to treat a type of skin disease due to certain findings during an inspection of a contract manufacturer, the company said

Goldman Sachs' Chris Shibutani talks his top biotech picks including Eli Lilly and Pfizer

05:43pm, Friday, 29'th Sep 2023

Chris Shibutani, Goldman Sachs Senior Analyst, joins 'Closing Bell Overtime' to talk his top picks in the biotech sectors.

3 Stocks to Focus on as Demand for Obesity Drugs Booms

11:17am, Friday, 29'th Sep 2023

The market for obesity and weight management drugs is attracting a lot of interest lately in the United States. Patients are gradually understanding the benefits of obesity drugs like Novo Nordisk's N

Eli Lilly settles whistleblower lawsuit over manufacturing problems

05:18pm, Thursday, 28'th Sep 2023

Eli Lilly and Co and a former employee agreed to settle a lawsuit in which the worker claimed she was terminated after pointing out poor manufacturing practices and data falsification involving one of

3 Biotech Stocks to Watch Ahead of Potential Obesity Drug Approvals

08:45am, Thursday, 28'th Sep 2023

The companies that already have obesity drugs can't keep up with the demand for their treatments, and the demand for the drugs is only likely to become more intense. That's because over 42% of the U.S

US judge overturns Eli Lilly's $176.5 million loss in Teva patent case

04:34pm, Tuesday, 26'th Sep 2023

Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that found Lilly's migraine drug Emgality infringed three pa

Don't Miss the Boom: 3 Biotech Stocks Set to Explode Higher

01:00pm, Tuesday, 26'th Sep 2023

In the dynamic investment realm, one sector that continues to stand out is the area of biotech stocks. Though risky, especially when assessing established firms with market-ready drugs and vast resear

2 Magnificent Dividend Stocks to Buy Right Now

01:00pm, Tuesday, 26'th Sep 2023

High-quality dividend stocks frequently produce market-beating returns over the long term. Eli Lilly and Novo Nordisk are two blue-chip dividend stocks with rock-solid payouts and strong growth prospe

FDA Expands Lilly (LLY) Jardiance Label in Chronic Kidney Disease

01:32pm, Monday, 25'th Sep 2023

Following the latest approval, Lilly's (LLY) Jardiance can access a target market that affects more than 35 million adults in the United States.

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know

10:31am, Monday, 25'th Sep 2023

Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

The disruptive effect of weight loss drugs like Ozempic could have surprising impacts on the stock market. Here are potential winners and losers.

08:30am, Sunday, 24'th Sep 2023

The potential ripple effects of GLP-1 weight loss drugs like Ozempic and Wegovy are far-reaching. There could be reduced demand for junk food and increased demand for athletic brands.

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by